176 related articles for article (PubMed ID: 24894092)
21. Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.
Belle S; Han F; Condomines M; Christensen O; Witzens-Harig M; Kasper B; Kleist C; Terness P; Moos M; Cremer F; Hose D; Ho AD; Goldschmidt H; Klein B; Hundemer M
Eur J Haematol; 2008 Jul; 81(1):26-35. PubMed ID: 18363871
[TBL] [Abstract][Full Text] [Related]
22. Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.
Yousef S; Heise J; Lajmi N; Bartels K; Kröger N; Luetkens T; Atanackovic D
J Transl Med; 2015 Jun; 13():197. PubMed ID: 26088750
[TBL] [Abstract][Full Text] [Related]
23. HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.
Olson BM; Frye TP; Johnson LE; Fong L; Knutson KL; Disis ML; McNeel DG
Cancer Immunol Immunother; 2010 Jun; 59(6):943-53. PubMed ID: 20140431
[TBL] [Abstract][Full Text] [Related]
24. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
[TBL] [Abstract][Full Text] [Related]
25. Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma.
Choi C; Witzens M; Bucur M; Feuerer M; Sommerfeldt N; Trojan A; Ho A; Schirrmacher V; Goldschmidt H; Beckhove P
Blood; 2005 Mar; 105(5):2132-4. PubMed ID: 15561890
[TBL] [Abstract][Full Text] [Related]
26. Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.
Atanackovic D; Hildebrandt Y; Jadczak A; Cao Y; Luetkens T; Meyer S; Kobold S; Bartels K; Pabst C; Lajmi N; Gordic M; Stahl T; Zander AR; Bokemeyer C; Kröger N
Haematologica; 2010 May; 95(5):785-93. PubMed ID: 20015885
[TBL] [Abstract][Full Text] [Related]
27. Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma.
Goodyear OC; Pearce H; Pratt G; Moss P
Cancer Immunol Immunother; 2011 Dec; 60(12):1751-61. PubMed ID: 21785964
[TBL] [Abstract][Full Text] [Related]
28.
Khalaf WS; Garg M; Mohamed YS; Stover CM; Browning MJ
Front Immunol; 2019; 10():1792. PubMed ID: 31428094
[TBL] [Abstract][Full Text] [Related]
29. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
30. A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma.
Bae J; Song W; Smith R; Daley J; Tai YT; Anderson KC; Munshi NC
Br J Haematol; 2012 Jun; 157(6):687-701. PubMed ID: 22533610
[TBL] [Abstract][Full Text] [Related]
31. Identification of CD8
Ma N; Liu H; Zhang Y; Liu W; Liang Z; Wang Q; Sun Y; Wang L; Li Y; Ren H; Dong Y
Front Immunol; 2022; 13():927804. PubMed ID: 35967402
[TBL] [Abstract][Full Text] [Related]
32. Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma.
Kang YJ; Zeng W; Song W; Reinhold B; Choi J; Brusic V; Yamashita T; Munshi A; Li C; Minvielle S; Anderson KC; Munshi N; Reinherz EL; Sasada T
Br J Haematol; 2013 Nov; 163(3):343-51. PubMed ID: 24032635
[TBL] [Abstract][Full Text] [Related]
33. Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.
Oostvogels R; Minnema MC; van Elk M; Spaapen RM; te Raa GD; Giovannone B; Buijs A; van Baarle D; Kater AP; Griffioen M; Spierings E; Lokhorst HM; Mutis T
Leukemia; 2013 Mar; 27(3):642-9. PubMed ID: 23079962
[TBL] [Abstract][Full Text] [Related]
34. Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy.
de Carvalho F; Vettore AL; Colleoni GW
Clin Dev Immunol; 2012; 2012():257695. PubMed ID: 22481966
[TBL] [Abstract][Full Text] [Related]
35. Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma.
Bilich T; Nelde A; Bauer J; Walz S; Roerden M; Salih HR; Weisel K; Besemer B; Marcu A; Lübke M; Schuhmacher J; Neidert MC; Rammensee HG; Stevanović S; Walz JS
Blood Cancer J; 2020 Feb; 10(2):24. PubMed ID: 32111817
[TBL] [Abstract][Full Text] [Related]
36. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B
J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation generates T cell-dependent control of myeloma in mice.
Vuckovic S; Minnie SA; Smith D; Gartlan KH; Watkins TS; Markey KA; Mukhopadhyay P; Guillerey C; Kuns RD; Locke KR; Pritchard AL; Johansson PA; Varelias A; Zhang P; Huntington ND; Waddell N; Chesi M; Miles JJ; Smyth MJ; Hill GR
J Clin Invest; 2019 Jan; 129(1):106-121. PubMed ID: 30300141
[TBL] [Abstract][Full Text] [Related]
38. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
Abu-Khader A; Krause S
Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
[TBL] [Abstract][Full Text] [Related]
39. Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma.
Fichtner S; Hose D; Engelhardt M; Meißner T; Neuber B; Krasniqi F; Raab M; Schönland S; Ho AD; Goldschmidt H; Hundemer M
Clin Cancer Res; 2015 Apr; 21(7):1712-21. PubMed ID: 25609061
[TBL] [Abstract][Full Text] [Related]
40. Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.
Siegel S; Wagner A; Friedrichs B; Wendeler A; Wendel L; Kabelitz D; Steinmann J; Barsoum A; Coggin J; Rohrer J; Dreger P; Schmitz N; Zeis M
J Immunol; 2006 Jun; 176(11):6935-44. PubMed ID: 16709854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
